Citation Impact
Citing Papers
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
2010
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Risk‐adjusted relationship between voriconazole utilization and non‐melanoma skin cancer among lung and heart/lung transplant patients
2013
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
2014
Risk factors for reperfusion injury after lung transplantation
2006
Idiopathic pulmonary fibrosis
2017 Standout
Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis
2013
A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease
2008
CONTINUOUS INFUSION OF NITROGLYCERIN IMPROVES PULMONARY GRAFT FUNCTION OF NON???HEART-BEATING DONOR LUNGS
2004
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match
2019 Standout
The Acute Respiratory Distress Syndrome
2000 Standout
Immunosuppressive therapy in lung transplantation: state of the art
2009
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
2003
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients
2005
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Cytomegalovirus and Lung Transplantation
2004
Aciclovir
1994
Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients
2012
Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation
2012
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Lung Transplantation: A Decade of Experience
1999
Ganciclovir
2018
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures
2014
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease
2008
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
2013
Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation
2000
Clinical Exercise Testing
2001
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Bronchiolitis Obliterans Syndrome: Alloimmune-Dependent and -Independent Injury with Aberrant Tissue Remodeling
2008
Predictors of Chronic Kidney Disease in Long-Term Survivors of Lung and Heart-Lung Transplantation
2006
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
2020 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Pediatric Lung Transplantation
2010
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis
2011
Idiopathic pulmonary fibrosis
2017 Standout
Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed
2007
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients
2003
Idiopathic Pulmonary Fibrosis
2001 Standout
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
ABO Incompatible Renal Transplantation Without Antibody Removal Using Conventional Immunosuppression Alone
2014
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time
2017 Standout
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Cytolytic Therapy for the Bronchiolitis Obliterans Syndrome Complicating Lung Transplantation
1996
Natural compounds for cancer treatment and prevention
2009 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
2011
Infection in Solid-Organ Transplant Recipients
2007 Standout
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
2014
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Influenza vaccination in solid-organ transplant recipients
2012
Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China
2013
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients
2013
Predictive Utility of the 6-Minute Walk Distance on Survival in Patients Awaiting Lung Transplantation
2008
A Randomized Study of Endobronchial Valves for Advanced Emphysema
2010
The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant
2015
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Alveolar Epithelial Fluid Transport Capacity in Reperfusion Lung Injury after Lung Transplantation
1999
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
2015
Use of Lung Allografts from Brain-Dead Donors after Cardiopulmonary Arrest and Resuscitation
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
SHORT-TERM ???PRECONDITIONING??? WITH INHALED NITRIC OXIDE PROTECTS RABBIT LUNGS AGAINST ISCHEMIA-REPERFUSION INJURY1
2001
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Mechanisms of Antibiotic Resistance
2016 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Primary Graft Failure after Heart Transplantation
2011
Infections in solid-organ transplant recipients
1997
Varicella-zoster virus
1996 Standout
Passenger Lymphocyte Syndrome and Liver Transplantation
2008
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
2011
Aspergillus fumigatusand Aspergillosis
1999 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Is universal antifungal prophylaxis mandatory in lung transplant patients?
2013
Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
2012
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Changing Face of Vaccination in Immunocompromised Hosts
2014
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Influence of graft ischemic time and donor age on survival after lung transplantation
1999
Infection after lung transplantation.
1993
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Clopidogrel reduces post-transplant obliterative bronchiolitis
2013
Works of G. Snell being referenced
Antifungal Prophylaxis in Lung Transplantation—A World-wide Survey
2011
Outcomes of patients with interstitial lung disease referred for lung transplant assessment
2006
The Impact of Pandemic Influenza A H1N1 2009 on Australian Lung Transplant Recipients
2011
Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis
2000
Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
2002
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients
2002
Lung Transplantation in Pulmonary Fibrosis: Challenging Early Outcomes Counterbalanced by Surprisingly Good Outcomes Beyond 15 Years
2009
Lessons and Insights From ABO-Incompatible Lung Transplantation
2013
Excellent Clinical Outcomes From a National Donation-After-Determination-of-Cardiac-Death Lung Transplant Collaborative
2012
133Xenon ventilation scintigraphy applied to bronchoscopic lung volume reduction techniques for emphysema: relevance of interlobar collaterals
2005
Association between Primary Graft Dysfunction among Lung, Kidney and Heart Recipients from the Same Multiorgan Donor
2008
Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome
2011
A ‘Dangerous’ Group O Donor: Severe Hemolysis in All Recipients of Organs from a Donor with Multiple Red Cell Alloantibodies
2008
Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation
2010
High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation
2005
Everolimus Versus Azathioprine in Maintenance Lung Transplant Recipients: An International, Randomized, Double-Blind Clinical Trial
2005
Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens.
1993
Bronchial hyperresponsiveness in lung transplant recipients: lack of correlation with airway inflammation
1997
Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation.
1996
Preemptive treatment with voriconazole in lung transplant recipients
2013
Immunopathological changes in the airways of stable lung transplant recipients
1997
Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours.
1993
Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids.
2000
Exercise, potassium, and muscle deconditioning post-thoracic organ transplantation
1994